Science Spyglass
Unlocking the Power of Thermal Shift Assays for Early-Stage Drug Discovery
Thermal Shift Assays (TSA) provide valuable insights into protein stability, ligand interactions, and quality control, making them indispensable for drug development and protein engineering.
Key Takeaways
- TSA supports protein stability and ligand binding studies
- Compatible with high-throughput screening workflows
- Enables efficient hit validation and protein characterization
- Seamlessly integrates with our biochemical assay capabilities
Why it matters in Drug Discovery?
Thermal Shift Assays are widely used in early-stage drug discovery because they combine low sample consumption, scalability, and rapid experimental execution.
They provide a fast and cost-effective way to assess protein stability and ligand binding, supporting informed decision-making from hit identification through lead optimization.
Key applications include:
- Hit identification by screening compound libraries for molecules that stabilize or destabilize the target protein
- Protein characterization by assessing thermal stability and mutation effects
- Ligand engagement studies to confirm protein–ligand interactions
- Affinity and inhibition analysis, including estimation of binding parameters (Kd) and inhibitor potency
- Quality control for evaluating protein stability and formulation consistency
Additionally, TSA enables the ranking of compounds based on their affinity to the target protein, providing valuable insights into their binding properties. By using TSA, researchers can confidently evaluate compounds and identify those with a higher or lower affinity to the target protein, aiding in drug discovery and optimization processes.
Thermal Shift Assays (TSA) are a versatile tool that can support multiple stages of early drug discovery. They are particularly recommended for:
- Primary screening of small, focused, or unbiased compound libraries, where TSA enables the rapid identification of promising compounds for further investigation.
- Secondary assays for hit validation and target engagement, providing additional evidence of direct interactions between compounds and target proteins to further validate potential hits.
- Characterizing lead compounds during the hit-to-lead phase, providing crucial information on their stability and binding properties to support the selection of the most viable candidates for further development.
- For the identification of proteolysis targeting chimera (PROTACTM) scaffold molecules. The interactions between PROTACs and target proteins can be assessed by utilizing TSA, facilitating the development of effective protein-degradation strategies.
- Characterization of protein variants and mutants, enabling researchers to study how mutations affect protein stability and ligand interactions.
In addition to these applications, TSA offers several practical advantages over traditional protein stability methods. It is simple, rapid, and cost-effective, requires relatively small amounts of protein, and can be easily miniaturized to 384-well plate formats, making it suitable for medium- and high-throughput screening workflows.
What are Thermal Shift Assays?
TSA is a highly parallelizable, cost-effective technique for studying protein stability and protein binders.
It measures the thermal denaturation of a target protein by monitoring the fluorescence intensity of a dye that binds to exposed hydrophobic regions of the protein during heating. As the protein unfolds, the exposed hydrophobic regions increase, leading to an increase in fluorescence signal.
Compounds, such as inhibitors or in general modulators, stabilize the three-dimensional conformation of the target protein and as a consequence the temperature needed to denature the protein is higher (see purple curve)
The figure shows fluorescence intensity curves (top panel). The blue curve is the target protein with the dye; the other traces correspond to the addition of increasing concentration of a binder compound that causes a shift of the melting temperature of the protein complex. The melting temperature can be calculated as the inflection point of the fluorescence intensities or as the first derivative of the curves (peaks in the bottom panel).
TSA and differential scanning fluorimetry (DSF) can generally be used interchangeably, a primary distinguishing feature between the two lies in their denaturation methods.
TSA specifically refers to the denaturation of a target protein triggered solely by temperature intensification. On the other hand, DSF encompasses techniques that employ various physicochemical agents, including but not limited to temperature intensification, in order to induce denaturation in the target protein. In this article, our focus will be directed towards exploring the specific aspects of TSA.
The TSA methodology involves a series of simple steps that make it suitable for routine laboratory use.
The following is a brief outline of the key steps involved in performing a TSA experiment:
- Protein sample preparation: purify the protein of interest ≥ 90% using established protocols, ensuring its quality and concentration.
- Fluorescent dye binding: add a fluorescent dye, such as SYPROTM Orange (a gold standard dye), to the protein solution. The dye selectively binds to hydrophobic regions exposed during protein unfolding.
- Thermal gradient generation: set up a thermal gradient by using a thermocycler. Typically, the temperature is increased in small increments, allowing for gradual protein denaturation.
- Fluorescence detection: monitor the fluorescence intensity of the dye at each temperature increment. The increase in fluorescence corresponds to protein denaturation.
- Data analysis: analyze the thermal-shift data to determine the protein melting temperature (Tm), which represents the temperature at which 50% of the protein is unfolded. Tm provides insights into protein stability and ligand interactions.
Axxam’s Thermal Shift Assays capabilities
Axxam provides Thermal Shift Assay (TSA), also known as Differential Scanning Fluorimetry (DSF), services for early-stage drug discovery. These assays can be seamlessly integrated into scalable drug discovery workflows to accelerate hit identification, compound evaluation, protein characterization, and decision-making.
TSA instrument platform
Our TSA experiments are conducted using advanced thermocyclers that allow for the creation of precise temperature gradients ranging from 20 to 100 °C. These instruments are equipped with the capability to accurately read the fluorescence emission of SYPROTM Orange dye, supplying reliable data for your TSA analysis.
Screening compatibility
For projects requiring higher throughput, we have the capability to run TSA in a 384-well plate format. This screening choice allows for efficient analysis of a larger number of samples. Moreover, we have integrated suitable instruments into our automated screening station, ensuring streamlined processes and precise data acquisition.
Production of target protein in-house
Our highly experienced biochemistry unit has the expertise to produce the required quantities of your target protein. Whether you need wild-type or truncated forms, we can generate the proteins in-house, ensuring quality control and efficiency in the process.
Proprietary fluorescent dye library
Notably reported in literature, SYPROTM Orange dye works with around 70% of soluble proteins and for this reason we developed a proprietary dye library based on the binding mechanism of SYPROTM Orange but with diverse chemical scaffolds unrelated to this particular dye. Thus, if the target protein is not TSA-detectable with SYPROTM Orange, we have the possibility to screen our dye library with the aim of obtaining useful data using a different dye.
Integrated screening and profiling options
By leveraging our TSA capabilities, you can benefit from our in-house protein production, advanced instrument platform, and screening and profiling options. We are committed to providing reliable and efficient TSA services to support your research and drug discovery endeavors.
TSA within integrated drug discovery workflows
As a biophysical method within integrated drug discovery workflows, TSA is typically combined with other biochemical assays to enable orthogonal confirmation and functional characterization.
FAQ
Thermal Shift Assays (TSA) offer several advantages for protein characterization and early-stage drug discovery, including:
- Cell-free, label-free, and immobilization-free analysis of protein–ligand interactions.
- No need to label the target protein, simplifying assay development and reducing experimental complexity.
- Fast and cost-effective workflows that save time and resources.
- Low protein consumption compared with many traditional biophysical methods.
- Compatibility with miniaturized formats, such as 384-well plates, making TSA suitable for medium- and high-throughput screening.
- Broad applicability for studying protein stability, ligand binding, and the effects of protein mutations.
Despite its many benefits, TSA has some limitations:
- It relies on the assumption that protein unfolding exposes hydrophobic regions, which is not true for every protein and may lead to inaccurate results for proteins with complex unfolding profiles.
- Complementary techniques may be required to obtain a more complete understanding of protein stability in certain cases.
- TSA is not always suitable for membrane-bound proteins, such as GPCRs, because their naturally exposed hydrophobic regions can generate high background fluorescence and interfere with standard melting curve analysis.
- For challenging protein classes, alternative methods or specialized fluorogenic dyes may be needed to achieve reliable measurements.
Overall, TSA remains a versatile and widely adopted technique that supports protein characterization, ligand binding studies, and drug discovery, while delivering the best results when applied to appropriate targets and experimental conditions. architecto quis delectus perspiciatis.
Related content
Thermal Shift Assays meet HTS to discover and characterize novel protein binders